Jan 12, 2021
IsoPlexis' IsoSpark Wins 2021 BIG Innovation Award
Dec 01, 2020
The Scientist Names IsoPlexis Single Cell Intracellular Proteome a Top 10 Innovation of 2020
Nov 25, 2020
IsoPlexis to Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 2, 2020
Nov 11, 2020
IsoPlexis Launches Personalized Lab System, the IsoSpark, to Continue Scaling to Many Labs Worldwide
Oct 08, 2020
IsoPlexis and Yale Partner to Advance COVID-19 Immune Profiling Biomarkers
Aug 25, 2020
IsoPlexis Announces "Single-Cell Proteomics Grant Challenge: COVID-19"
Aug 20, 2020
IsoPlexis and Lonza Collaborate to Enable the Next Generation of Precision Cell Therapy Manufacturing
Aug 14, 2020
IsoPlexis Adds Partnership to Advance COVID-19 Vaccine Development
Aug 04, 2020
FlowMetric Life Sciences, Inc. selected as IsoPlexis Certified Service Provider
Jul 28, 2020
IsoPlexis Announces Partnership with Neoline Technology Co & IsoLight Expansion into Chinese Life Science Market
Jun 26, 2020
IsoPlexis Strengthens Commercial Leadership with the Appointment of Peter Siesel as Chief Commercial Officer
Mar 12, 2020
IsoPlexis Launches Suite of New Products Enabling Multiple Automated Applications on the IsoLight
Dec 09, 2019
IsoPlexis Announces "Cracking the IsoCode: Single Cell Functional Biomarkers Challenge"
Oct 03, 2019
IsoPlexis' New Software & Applications Pave the Way for Novel Functional Understanding of Single-Cell Immune Activation and Further Application Expansion
Sep 30, 2019
IsoPlexis' Immune Monitoring Contributions in Precision Medicine Highlighted in Comprehensive Publication, "Biomarkers for Immunotherapy of Cancer"
Sep 26, 2019
IsoPlexis Continues Progress on Precision CAR-T cell Characterization with Recent Data Sets & Miltenyi Biotec, Inc. Technology Note
Aug 01, 2019
IsoPlexis Launches First European Office & Initial IsoLight Single Cell Cytokine Detection System at Karolinska Institute in Sweden
Jun 21, 2019
IsoPlexis Receives $4 Million National Cancer Institute Grant for Commercialization of IsoLight for CAR-T Functional Quality Profiling
May 14, 2019
IsoPlexis Completes $25 Million Series C Financing
Aug 20, 2018
IsoPlexis Announces Expansion into Asia Pacific